Health News Releases

11:20

Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery

Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54161904&newsitemid=20241205693431&lan=en-US&anchor=Parse+Biosciences&index=1&md

December 05, 13:50

Nurse Maria Victoria Juan From Philippines Wins the Prestigious Aster Guardians Global Nursing Award 2024

Nurse Maria Victoria Juan from Philippines, a Consultant at Philippines Army Health Services and Colonel, Reserve Force of the Armed Forces of the Philippines, has been announced as the winner of the

December 05, 10:45

Avania Appoints Innovative Operations Strategist Charlene Dark as New Chief Operating Officer

Avania (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.avaniaclinical.com%2F&esheet=54160539&newsitemid=20241203677092&lan=en-US&anchor=Avania&index=1&md5=4b5f83247ba447bb7edd17

December 04, 10:45

Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics

Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=54160718&newsitemid=20241202182459&lan=en-US&anchor=TSE%3A4502%2FNYSE%

December 02, 14:15

GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical

GE HealthCare (Nasdaq: GEHC) has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing from Sumitomo Chemical (TYO: 4005) the 50% stake it does not already own. As part

November 29, 09:23

Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis

Galderma (SWX:GALD) today announced that full results from the phase III OLYMPIA 1 trial, a 24-week study which evaluated the efficacy and safety of nemolizumab monotherapy in adults with moderate-to-

November 28, 10:15

U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting

AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug Administration (FDA) has granted regulatory approval for Rapiblyk™ (landiolol) in the hosp

November 27, 16:00

Viromed Medical AG: Cold Plasma as a Digital Antibiotic for the Lungs

Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65; “Viromed”) is pushing forward research into cold plasma for the prevention of ventilator-associated pneumonia (VAP). Under the scientific directio

November 24, 11:10

Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials Landscape

Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha

November 22, 16:40

Rigaku BioScience Lab Opens in USA

Rigaku Corporation, a Rigaku Holdings Group company that serves as a global solution partner for X-ray analytical equipment (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; “Rigaku”), opened Rigaku

November 22, 10:50

Global Cell and Gene Therapy Trials: Driving Innovation in Oncology and Beyond

Novotech, the global full-service clinical Contract Research Organization (CRO), has published its latest whitepaper, offering in-depth analysis and emerging trends and advancements within the rapidly

November 22, 09:55

The Future of Diffuse Large B-Cell Lymphoma (DLBCL) Treatment: Insights from Global Research

Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, sh

November 21, 11:40

Novotech Releases Report on Global Bladder Cancer Clinical Trials, Offering Insights for Oncology Advancement

Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha

November 20, 17:10

NationsBenefits Acquires Good Measures to Revolutionize Food as Medicine Solutions

NationsBenefits®, the leading fintech, benefits, and outcomes platform for healthcare, announced the acquisition of Good Measures, the leading platform for Food as Medicine supporting health plans and

November 20, 15:30

Pharmanovia Signs Novel Biologic In-Licensing Agreement With Lindis Biotech to Commercialise Catumaxomab for Treatment of Rare Condition, Malignant Ascites

Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines, has today announced the expansion of its o

November 19, 15:50

HistoSonics® Enrolls First Patients in Company’s Novel BOOMBOX Master Study

HistoSonics, the developer and manufacturer of the Edison® Histotripsy System, announced today the first patients were enrolled in their novel prospective master protocol study, called BOOMBOX, design

November 19, 11:35

Novotech Releases Comprehensive Report on the Global Clinical Trial Landscape for Small Cell Lung Cancer (SCLC)

Novotech, the global full-service clinical Contract Research Organization (CRO), has published a new report, Small Cell Lung Cancer: Global Clinical Trial Landscape 2024 (https://cts.businesswire.com/

November 17, 15:40

BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer

BeiGene, Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54152783&newsitemid=20241114671168&lan=en-US&anchor=BeiGene&index=1&md5=e4496ffaca181720a54a2

November 15, 16:00

Rigaku Develops Technology for 3D Visualization of the Atomic-scale Structure of Amorphous Carbon

The X-ray Laboratory of Rigaku Corporation, a Rigaku Holdings Group company and a global solution partner for X-ray analysis (headquarters: Akishima, Tokyo; president and CEO: Jun Kawakami; “Rigaku”),

November 15, 13:50

BeiGene Announces Third Quarter 2024 Financial Results and Corporate Updates

BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54150961&newsitemid=20241112799807&lan=en-US&anchor=BeiGene&index=1&md5=4e5a672b984a991400376fd3071

November 15, 11:10

Medidata Secures Highest Leadership Position in Everest Group’s First Life Sciences Clinical Trial Management System Products PEAK Matrix® Assessment

Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2F&esheet=54151986&newsitemid=20241112190210&lan=en-US&anchor=Medidata&index=1&md5=13f9038490d8f84d037

November 14, 14:00

QPS Launches New Leukopak and Cell Therapy Products Facility

QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy business unit. The unit’s first achievement is the opening of a new Leukopak collection a

November 14, 11:10

Center for Disease Analysis Foundation Receives $7 Million Grant from the John C. Martin Foundation to Support the Polaris Observatory

The Center for Disease Analysis (CDA) Foundation is pleased to announce receipt of a $7 million grant from the John C. Martin Foundation to sustain and expand the Polaris Observatory until the end of

November 14, 10:30

Novotech Releases In-Depth Report on Cervical Cancer: Addressing a Global Health Challenge

Novotech, the global full-service clinical Contract Research Organization (CRO), has released a new report, Cervical Cancer - Global Clinical Trial Landscape (https://cts.businesswire.com/ct/CT?id=sma

November 13, 15:50

Medidata and Bioforum Bolster Decade-Long Relationship to Advance Clinical Data and Biometric Solutions for Clinical Trials

Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2F&esheet=54151261&newsitemid=20241112963841&lan=en-US&anchor=Medidata&index=1&md5=1aed735279447556547

News by Region

News by Industry